CapeOX | mFOLFOX6 | UFT/LV | Capecitabine | S-1 | P | |
---|---|---|---|---|---|---|
Gender† | ||||||
Male/female | 32/25 | 5/5 | 20/18 | 10/10 | 18/11 | 0.909a |
Age‡ | 65.0 (79-40) | 55.5 (73-41) | 67.0 (79-40) | 60.0 (78-40) | 63.0 (80-42) | 0.309b |
Tumor type | ||||||
Colon cancer/rectal cancer† | 35/22 | 9/1 | 27/11 | 15/5 | 17/12 | 0.372a |
Stage† | ||||||
I / II / III | 0/3/54 | 0/0/10 | 0/11/27 | 0/2/18 | 4/11/14 | <0.001a |
Performance status† | ||||||
0/1 | 57/0 | 10/0 | 35/3 | 18/2 | 29/0 | 0.0680a |